Unknown

POCD After Major Gynecologic Surgery

The Effect of Intravenous Dexketoprofen on the Severity and Incidence of Rebound Pain

Individualized Nutrition Intervention in Children With Cerebral Palsy

Electrolytic Surface Decontamination in the Surgical Treatment of Peri-implantitis: A Randomized Clinical Trial

Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After Lobectomy

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

A Modular Cloud Platform For Fertility Preservation

Gluten-Free vs Mediterranean Diet in Rheumatoid Arthritis

Self-Help Plus (SH+) for Stress Reduction in Social Service Workers: A Pilot RCT

Primary Dysmenorrhea and Mobilization.

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Home Environmental Risks and Caregiver Awareness

A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4)

Sensory Feeding and Parent Coaching for Children With ARFID